APA (7th ed.) Citation

M, V., R, Z., R, L., JK, R., HH, H., JS, H., & H, K. (2025). 4-O-Demethylbarbatic acid has a novel therapeutic impact on the progression of EGFR-driven lung adenocarcinoma. Phytomedicine : international journal of phytotherapy and phytopharmacology, 145, 156973. https://doi.org/10.1016/j.phymed.2025.156973

Chicago Style (17th ed.) Citation

M, Varlı, Zhou R, Liu R, Rho JK, Ha HH, Hur JS, and Kim H. "4-O-Demethylbarbatic Acid Has a Novel Therapeutic Impact on the Progression of EGFR-driven Lung Adenocarcinoma." Phytomedicine : International Journal of Phytotherapy and Phytopharmacology 145 (2025): 156973. https://doi.org/10.1016/j.phymed.2025.156973.

MLA (9th ed.) Citation

M, Varlı, et al. "4-O-Demethylbarbatic Acid Has a Novel Therapeutic Impact on the Progression of EGFR-driven Lung Adenocarcinoma." Phytomedicine : International Journal of Phytotherapy and Phytopharmacology, vol. 145, 2025, p. 156973, https://doi.org/10.1016/j.phymed.2025.156973.